Qube Research & Technologies LTD Health Catalyst, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 93,552 shares of HCAT stock, worth $649,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,552
Previous 166,591
43.84%
Holding current value
$649,250
Previous $1.06 Million
28.48%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HCAT
# of Institutions
170Shares Held
49.7MCall Options Held
2.86MPut Options Held
56.4K-
Black Rock Inc. New York, NY5.43MShares$37.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.58MShares$31.8 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN4.3MShares$29.8 Million3.05% of portfolio
-
Impax Asset Management Group PLC2.55MShares$17.7 Million0.09% of portfolio
-
Daventry Group, LP New York, NY2.42MShares$16.8 Million7.83% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $380M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...